Cubist Systematic Strategies, LLC Penumbra Inc Put Options Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$163.64 - $210.12 $81,820 - $105,060	-500 Reduced 27.78%	1,300 $252,000
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $344,540 - $447,900	-2,000 Reduced 52.63%	1,800 $323,000
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $308,126 - $382,409	-1,400 Reduced 26.92%	3,800 $848,000
Q4 2023 Feb 14, 2024	SELL	$181.44 - $260.22 $199,584 - $286,242	-1,100 Reduced 17.46%	5,200 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $1.52 Million - $2.13 Million	6,300 New	6,300 $1.52 Million

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.